Urosphere Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Urosphere General Information

Description

Operator of a research organization intended to offer treatment in preclinical urogenital, gastro-intestinal, and oncological pharmacology assays. The company's unique experimental research platform combining both in vivo models and in vitro assays on human and animal tissues, establishes preclinical proof of concept for drug candidates, enabling pharmaceutical and biopharmaceutical industries to maintain a trustworthy relationship with partners and provide the highest quality services.

Contact Information

Website
www.urosphere.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Canal Biotech Ii 3
  • Rue Des Satellites
  • 31400 Toulouse
  • France
+33 05
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, Life Sciences, Oncology
Corporate Office
  • Canal Biotech Ii 3
  • Rue Des Satellites
  • 31400 Toulouse
  • France
+33 05

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Urosphere Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Urosphere’s complete valuation and funding history, request access »

Urosphere Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Urosphere Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220340881-A1 Method for differentiating epithelial stem cells Pending 09-Aug-2019
AU-2020327593-A1 Method for differentiating epithelial stem cells Pending 09-Aug-2019
EP-3772538-A1 Method for differentiating epithelial stem cells Inactive 09-Aug-2019
EP-4010460-A1 Method for differentiating epithelial stem cells Pending 09-Aug-2019
CA-3149332-A1 Method for differentiating epithelial stem cells Pending 09-Aug-2019 C12N5/0697
To view Urosphere’s complete patent history, request access »

Urosphere Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Urosphere Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nubbo Accelerator/Incubator Minority
To view Urosphere’s complete investors history, request access »

Urosphere Investments & Acquisitions (2)

Urosphere’s most recent deal was a Later Stage VC with Ixaltis for . The deal was made on 27-Jul-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ixaltis 27-Jul-2018 Later Stage VC Drug Discovery
Urolead 23-Nov-2017 Merger/Acquisition Biotechnology
To view Urosphere’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Urosphere FAQs

  • When was Urosphere founded?

    Urosphere was founded in 2004.

  • Where is Urosphere headquartered?

    Urosphere is headquartered in Toulouse, France.

  • What is the size of Urosphere?

    Urosphere has 19 total employees.

  • What industry is Urosphere in?

    Urosphere’s primary industry is Biotechnology.

  • Is Urosphere a private or public company?

    Urosphere is a Private company.

  • What is Urosphere’s current revenue?

    The current revenue for Urosphere is .

  • Who are Urosphere’s investors?

    Nubbo has invested in Urosphere.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »